Where science meets culture 
At the Vogel Foundation Dr Eckernkamp’s 25th anniversary gala at the Mainfranken Theater, #HIRI director Jörg Vogel emphasized the vital role of culture for cutting-edge research.
Congrats & thank you for supporting our science! 
https://www.helmholtz-hiri.de/en/newsroom/news/detail/news/where-science-meets-culture/
New year, new opportunities! 
Please spread the word: The #HIRI & @Uni_WUE's Faculty of Medicine are jointly inviting applications for 
HELMHOLTZ RESEARCH GROUPS WITH JUNIOR PROFESSORSHIPS (W1) in the areas of RNA-based infection research, microbial RNA biology and RNA-based medicine. The deadline for applications is January 19.
More information at https://helmholtz-hiri.de/en/w1-groups/
Fostering the #HIRI spirit! 
PhD student Chia-Ling Chou from Emmanuel Saliba's group has been awarded the 2024 HIRI Spirit Award for her exceptional efforts in organizing this year's HZI + IMIB PhD meeting. 
Congratulations, Chia! Read more: https://www.helmholtz-hiri.de/en/newsroom/news/detail/news/fostering-the-hiri-spirit/
Interested in phage therapy? @TWINCORE is hosting a mini-symposium on these “microbe eaters” and their role in infection research and medicine on November 13. Speakers include #HIRI group leader Jens Hör and Milan Gerovac, a former postdoc in the Vogel lab and now a group leader at @Helmholtz_HZI. Guests are welcome, and registration is not required! Learn more: https://www.twincore.de/en/events/news-details/news/mini-symposium-phage-therapy/
Job opportunity: The Helmholtz Institute Würzburg offers a postdoc position for the research project “Deciphering the binding rules of programmable RNA antibiotics.” Apply by August 18 to join the #HIRI team in beautiful Würzburg. More at www.helmholtz-hiri.de/en/jobs-talents/
The Helmholtz Institute Würzburg is looking for a #postdoc to join the research group of Jens Hör. #HIRI's Hör lab focuses on understanding the molecular mechanisms of #RNA #phages during infection, host takeover and anti-phage defense. More information: https://www.helmholtz-hiri.de/en/jobs-talents/working-at-hiri/
Passionate about phages? 
Apply by July 31 to join Jens Hör’s research group as a doctoral researcher! In #HIRI’s Hör lab, you will study how bacteria defend themselves against #RNA #phage infection and decipher the molecular mechanisms of this defense. More at: https://www.helmholtz-hiri.de/en/jobs-talents/working-at-hiri/
Laboratories provide controlled environments for experiments and measurements, fostering numerous inventions and discoveries. 
At the #HIRI, lab and infrastructure manager Christiane Albert-Weißenberger ensures that research in the lab runs smoothly.
In this interview, she talks about her work and responsibilities, the most exciting spot in the lab, and what the laboratories of the future might look like: https://www.helmholtz-hiri.de/en/newsroom/news/detail/news/what-lies-behind-the-research/
Attention, #RNA Community! 
Join us today at 4 PM CET for the #HIRI-hosted RNA Collaborative Seminar, featuring talks by HIRI director Jörg Vogel & Daniel Ryan, postdoc in the Westermann lab. Neva Caliskan will moderate the session. More at:
https://us02web.zoom.us/webinar/register/WN_NUfiHoOlRde2fhFSh7-XCw#/registration
The antimicrobial potential of #CRISPRCas systems is promising, yet how to best design or implement CRISPR nucleases remains poorly understood. An international team led by the #HIRI has now addressed this knowledge gap. The researchers conducted the first systematic interrogation of CRISPR antimicrobials using multidrug-resistant and hypervirulent bacteria as case studies, revealing wide variations in efficacy. Their findings were published in Nucleic Acids Research.
https://www.helmholtz-hiri.de/en/newsroom/news/detail/news/antimicrobial-agents-of-the-future/
Meet Janet Wackenreuter, who is exploring the world of small ribonucleic acids as part of the #HIRI graduate program “RNA & Infection”. 
Learn more about her journey to the institute and what she likes about #Würzburg at https://www.helmholtz-hiri.de/en/newsroom/features-stories/the-joy-of-discovery/
The World Antimicrobial Resistance Awareness Week (#WAAW) starts tomorrow, but at the #HIRI, the battle against #AntibioticResistance is a year-round task. 
We are searching for new targets in various germs, as conventional antibiotics are becoming increasingly ineffective: https://www.helmholtz-hiri.de/en/newsroom/features-stories/the-silent-pandemic/
One promising solution are programmable antibiotics, ASOs, studied by the laboratory of HIRI Director Jörg Vogel. They target #mRNAs needed by bacteria to synthesize new proteins & replicate.
More and more #antibiotics are losing their effectiveness as bacteria become resistant. But what can stop dangerous pathogens? Learn more about promising approaches using #CRISPR & designer molecules in this article with #HIRI department head Chase Beisel: https://www.livescience.com/health/medicine-drugs/dangerous-superbugs-are-a-growing-threat-and-antibiotics-cant-stop-their-rise-what-can
#CRISPR arrays are a compact way for nature to encode #gRNAs, but their ability to acquire new spacers keeps them longer than necessary for CRISPR technologies. #HIRI's Beisel lab now shows that CRISPR-Cas9 arrays can be shortened without compromising: https://doi.org/10.1080/15476286.2023.2247247
On this year’s International Day of Women and Girls in Science, we celebrate all our female #HIRI colleagues! 
Thank you for your passion for #RNA biology and #infection research. #WomenInScience
https://www.helmholtz-hiri.de/en/newsroom/news/detail/news/international-day-of-women-and-girls-in-science/
Here comes our #introduction:
We are the Helmholtz Institute for RNA-based Infection Research, #HIRI for short, and are part of the #Helmholtz @association. We combine ribonucleic acid (#RNA) research with #infection #biology.
Based on novel findings from our strong basic #research program, our long-term goal is to develop innovative therapeutic approaches to better diagnose and treat human infections.
Find more information about us here: https://www.helmholtz-hiri.de/en
(1/4)